Cargando…

Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study

OBJECTIVES: The ratio of ferritin to albumin (FAR) has been proposed as a novel prognostic indicator for COVID-19. However, the role of FAR in predicting the all-cause mortality rate in patients with sepsis has not been evaluated. Therefore, the aim of this study is to elucidate the correlation betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feng, Liu, Zhengting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563292/
https://www.ncbi.nlm.nih.gov/pubmed/37817258
http://dx.doi.org/10.1186/s40001-023-01405-y
_version_ 1785118308621615104
author Liu, Feng
Liu, Zhengting
author_facet Liu, Feng
Liu, Zhengting
author_sort Liu, Feng
collection PubMed
description OBJECTIVES: The ratio of ferritin to albumin (FAR) has been proposed as a novel prognostic indicator for COVID-19. However, the role of FAR in predicting the all-cause mortality rate in patients with sepsis has not been evaluated. Therefore, the aim of this study is to elucidate the correlation between FAR and the 28-day all-cause mortality rate in patients with sepsis. METHODS: This study used data from the Medical Information Mart for Intensive Care IV database (v2.0) for a retrospective cohort analysis. The study focused on adult patients with sepsis who were admitted to the intensive care unit. The primary objective was to assess the predictive capability of FAR in determining the 28-day all-cause mortality rate among patients with sepsis. RESULTS: The study involved 1553 sepsis patients in total. Based on the survival status of sepsis patients within 28 days, they were divided into two groups: a survival group consisting of 973 patients, and a death group consisting of 580 patients. The results revealed a 28-day mortality rate of 37.35% among sepsis patients. The multivariable Cox regression analysis revealed that FAR was an independent predictor of the 28-day all-cause mortality rate in patients with sepsis (hazard ratio [HR]: 1.17–1.19; 95% confidence interval 1.11–1.26; P < 0.001). The FAR demonstrated a higher area under the curve (AUC) of 61.01% (95% confidence interval 58.07–63.96%), compared to serum ferritin (60.48%), serum albumin (55.56%), and SOFA score (56.97%). Receiver operating characteristic curve (ROC) analysis determined the optimal cutoff value for FAR as 364.2215. Kaplan–Meier analysis revealed a significant difference in the 28-day all-cause mortality rate between patients with FAR ≥ 364.2215 and those with FAR < 364.2215 (P < 0.001). Furthermore, subgroup analysis showed no significant interaction between FAR and each subgroup. CONCLUSIONS: This study revealed a significant correlation between FAR and the 28-day mortality rate in patients with sepsis. Higher FAR values were strongly associated with increased mortality rates within 28 days.
format Online
Article
Text
id pubmed-10563292
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105632922023-10-11 Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study Liu, Feng Liu, Zhengting Eur J Med Res Research OBJECTIVES: The ratio of ferritin to albumin (FAR) has been proposed as a novel prognostic indicator for COVID-19. However, the role of FAR in predicting the all-cause mortality rate in patients with sepsis has not been evaluated. Therefore, the aim of this study is to elucidate the correlation between FAR and the 28-day all-cause mortality rate in patients with sepsis. METHODS: This study used data from the Medical Information Mart for Intensive Care IV database (v2.0) for a retrospective cohort analysis. The study focused on adult patients with sepsis who were admitted to the intensive care unit. The primary objective was to assess the predictive capability of FAR in determining the 28-day all-cause mortality rate among patients with sepsis. RESULTS: The study involved 1553 sepsis patients in total. Based on the survival status of sepsis patients within 28 days, they were divided into two groups: a survival group consisting of 973 patients, and a death group consisting of 580 patients. The results revealed a 28-day mortality rate of 37.35% among sepsis patients. The multivariable Cox regression analysis revealed that FAR was an independent predictor of the 28-day all-cause mortality rate in patients with sepsis (hazard ratio [HR]: 1.17–1.19; 95% confidence interval 1.11–1.26; P < 0.001). The FAR demonstrated a higher area under the curve (AUC) of 61.01% (95% confidence interval 58.07–63.96%), compared to serum ferritin (60.48%), serum albumin (55.56%), and SOFA score (56.97%). Receiver operating characteristic curve (ROC) analysis determined the optimal cutoff value for FAR as 364.2215. Kaplan–Meier analysis revealed a significant difference in the 28-day all-cause mortality rate between patients with FAR ≥ 364.2215 and those with FAR < 364.2215 (P < 0.001). Furthermore, subgroup analysis showed no significant interaction between FAR and each subgroup. CONCLUSIONS: This study revealed a significant correlation between FAR and the 28-day mortality rate in patients with sepsis. Higher FAR values were strongly associated with increased mortality rates within 28 days. BioMed Central 2023-10-10 /pmc/articles/PMC10563292/ /pubmed/37817258 http://dx.doi.org/10.1186/s40001-023-01405-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Feng
Liu, Zhengting
Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study
title Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study
title_full Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study
title_fullStr Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study
title_full_unstemmed Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study
title_short Association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study
title_sort association between ferritin to albumin ratio and 28-day mortality in patients with sepsis: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563292/
https://www.ncbi.nlm.nih.gov/pubmed/37817258
http://dx.doi.org/10.1186/s40001-023-01405-y
work_keys_str_mv AT liufeng associationbetweenferritintoalbuminratioand28daymortalityinpatientswithsepsisaretrospectivecohortstudy
AT liuzhengting associationbetweenferritintoalbuminratioand28daymortalityinpatientswithsepsisaretrospectivecohortstudy